Covid - 19 Tracking Application Create in Android Studio by using API Call ||
Covid - 19 Tracking Application Create in Android Studio by using API Call || #api #covid19-app
This App is made my API Call in android Studio .
🔗API Link :- https://corona.lmao.ninja/v2/all/
😇 Every 15 minites data will Update
What will see in the App ?
1. Cases
2. Today Cases
3. Deaths
4. Today Deaths
5. Recovered
6. Today Recoverd
7. Active Cases
8. Affected Countries
Android studio
#android #AndroidStudio #Corona
The COVID-19 pandemic in India is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case of COVID-19 in India, which originated from China, was reported on 30 January 2020.[5] India currently has the largest number of confirmed cases in Asia.[6] As of May 2021, India has the second-highest number of confirmed cases in the world (after the United States) with nearly 20 million reported cases of COVID-19 infection and 218,959 deaths as of 3 May 2021.[7][8]
The first cases of COVID-19 in India were reported in the towns of Thrissur, Alappuzha and Kasargod, all in the state of Kerala, among three Indian medical students who had returned from Wuhan.[9] Lockdowns were announced in Kerala on 23 March, and in the rest of the country on 25 March. By mid-May 2020, five cities accounted for around half of all reported cases in the country: Mumbai, Delhi, Ahmedabad, Chennai and Thane.[10] On 10 June, India's recoveries exceeded active cases for the first time.[11] Infection rates started to drop in September, along with the number of new and active cases.[12] Daily cases peaked mid-September with over 90,000 cases reported per-day, dropping to below 15,000 in January 2021.[13]
A second wave beginning in March 2021 was much larger than the first, with shortages of vaccines, hospital beds, oxygen cylinders and other medicines in parts of the country.[13] By late April, India led the world in new and active cases. On 30 April 2021, it became the first country to report over 400,000 new cases in a 24-hour period.[14][15] Experts believe that India's figures are vastly underreported due to poor infrastructure, low testing rates, and people dying at home.[15][16][17] [18]
India began its vaccination programme on 16 January 2021, and by April was administering 4 million doses a day.[19] India has authorised the British Oxford–AstraZeneca vaccine (Covishield), the Indian BBV152 (Covaxin) vaccine, and the Russian Sputnik V vaccine for emergency use. As of 1 May 2021, less than 2 percent of the population has been vaccinated.[20]
Vaccination
Main article: COVID-19 vaccination in India
COVID-19 vaccination queue on May 1st 2021 in Nagpur
India's Serum Institute of India licensed Oxford–AstraZeneca vaccine even before it was approved and built capacity to make 1.5–2.5 billion doses per year.[162] On 1 January 2021, the Drug Controller General of India granted an emergency use authorisation for the vaccine, which was branded "Covishield" for domestic use.[163][164] By this time, the company had stockpiled 50 million doses, but well short of its own target of 400 million.[163][162] The Government of India ordered 21 million doses to be delivered by February, but the company said no indication of any further orders were given.[20] So the company began to export the remaining stocks.[162] In March, after India saw a surge in COVID-19 cases, the Government put a block on all vaccine exports, and ordered 110 million doses from the Serum Institute.[20] The company plans to produce 100 million doses per month,[165] but it is unclear if the target has yet been reached.
In January, India also approved BBV152 (Covaxin), a domestic vaccine developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology.[166] This approval was met with some concern, as the vaccine had not then completed phase 3 trials.[167] Due to this status, those receiving Covaxin were required to sign a consent form,[168] while some states chose to relegate Covaxin to a "buffer stock" and primarily distribute the Oxford–AstraZeneca vaccine.[169] In April 2021, India approved the Russian Sputnik V vaccine and awarded emergency use authorisation to Dr. Reddy's Laboratories.[44][170] Several Indian companies have lined up to manufacture Sputnik V in India, to the tune of 850 million doses.[171][172] But the initial shipment of 150 million Sputnik V doses came from Russia, on 1 May.[173][174]
India officially launched its vaccination program on 16 January. Over 160,000 doses were administered on the first day.[175] By mid-April, it was reported that 108 million doses had been administered.[170] On 1 May 2021, the country began to offer vaccines to all residents 18 and over. Some states were unable to begin vaccination on the day due to shortage of vaccination supplies.[176]